NDC 58914-155-75 - PHOTOFRIN
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 58914-155
- Requested NDC
- 58914-155-75
- Package NDCs from labels
- 58914-155-75
- Manufacturer
- Axcan Scandipharm Inc.
- Effective date
- 2006-09-11
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| PHOTOFRIN ® (porfimer sodium) for Injection | Axcan Scandipharm Inc. | 2006-09-11 | HUMAN PRESCRIPTION DRUG LABELING |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| porfimer sodium | ACTIVE INGREDIENT | Y3834SIK5F | PHOTOFRIN (PORFIMER SODIUM) INJECTION, POWDER, FOR SOLUTION [AXCAN SCANDIPHARM INC.] | 1 | |
| porfimer | ACTIVE MOIETY | M15H03K69B | PHOTOFRIN (PORFIMER SODIUM) INJECTION, POWDER, FOR SOLUTION [AXCAN SCANDIPHARM INC.] | 1 | |
| hydrochloric acid | INACTIVE INGREDIENT | QTT17582CB | PHOTOFRIN (PORFIMER SODIUM) INJECTION, POWDER, FOR SOLUTION [AXCAN SCANDIPHARM INC.] | 1 | |
| sodium hydroxide | INACTIVE INGREDIENT | 55X04QC32I | PHOTOFRIN (PORFIMER SODIUM) INJECTION, POWDER, FOR SOLUTION [AXCAN SCANDIPHARM INC.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| C1D11818-1C0B-01AD-A563-2FDB5711A180 | F5FDDA24-DA7D-4E61-936E-9D1A55056B82 | 2006-09-11 | Warnings, Adverse reactions | C1D11818-1C0B-01AD-A563-2FDB5711A180 F5FDDA24-DA7D-4E61-936E-9D1A55056B82 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.